Moore David Scott bought CRVS

June 11, 2026 · Form 4 insider transaction

Moore David Scott bought 21,700 shares of Corvus Pharmaceuticals, Inc. at $11.53 per share, a transaction worth $250.2K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 4 days after the transaction.